AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vencure 37.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Curelogic Pharma

Salt Composition

Venlafaxine (37.5mg)

Overview Vencure 37.5mg Tablet ER

AnxioReduce 37.5mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, edginess, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take AnxioReduce 37.5mg ER with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon remembering; never skip doses, and complete the prescribed course, even with symptom improvement. Abrupt cessation may exacerbate symptoms. Common side effects include queasiness, vomiting, sleeplessness, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until the medication's effects are known. Most side effects are transient and self-limiting. Consult a physician if side effects persist or are bothersome. Before starting AnxioReduce 37.5mg ER, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor.

Uses of Vencure 37.5mg Tablet ER

Mood disorders encompassing sadness and worry.

Major Benefits of Vencure 37.5mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vencure 37.5mg Extended-Release Tablets should be administered with food.

Common Side effects of Vencure 37.5mg Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Vencure 37.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Vencure 37.5mg Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with food.

How Vencure 37.5mg Tablet ER works:

Vencure 37.5mg Extended-Release Tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vencure 37.5mg Extended-Release Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vencure 37.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vencure 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to infants. Close monitoring of infants for sufficient weight gain and any signs of excessive drowsiness is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Vencure 37.5mg Extended-Release Tablets, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vencure 37.5mg Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Vencure 37.5mg Extended-Release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Vencure 37.5mg Tablet ER :

Should you forget a Vencure 37.5mg Extended-Release Tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vencure 37.5mg Tablet ER

LabelValue
Chemical Category Anisole-based compound
Developing Habits No.
Type of Therapy Central Nervous System (CNS) Neurobiology
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Vencure 37.5mg Tablet ER

Yes, Vencure 37.5mg Extended-Release Tablets can cause drowsiness. Inform your doctor about any other sleep aids you're using before starting this medication.
Yes. Vencure 37.5mg Tablet ER is a psychotropic medication; this classification applies to any drug affecting mental processes, emotions, or behavior.
Vencure 37.5mg Extended-Release Tablets are not narcotics. Narcotics are opioid derivatives, such as heroin and morphine, known for their sleep-inducing effects.
Vencure 37.5mg tablets, both ER and XR formulations, are identical extended-release medications. This slow release maintains consistent therapeutic drug levels, reducing the frequency of dosing.
Mirtazapine and Vencure 37.5mg Tablet ER together pose a serious risk of serotonin syndrome. This potentially life-threatening condition can manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, unstable blood pressure, high fever, and coma.
Combining citalopram and Vencure 37.5mg ER tablets, which both raise serotonin levels, is risky. Serotonin syndrome, a potentially fatal condition with symptoms such as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma, may result. Use an alternative medication.
Vencure 37.5mg Tablet ER is actively removed from the brain by P-glycoprotein. However, some research indicates that this drug and its metabolite can also inhibit P-glycoprotein activity.
Vencure 37.5mg Extended-Release tablets are absorbed in the intestine following hepatic metabolism.
Vencure 37.5mg Extended-Release Tablets are used to manage major depressive disorder. Always consult your physician before use.
Treatment with Vencure 37.5mg Extended-Release tablets may cause a sustained rise in blood pressure in some individuals. Regular blood pressure monitoring is recommended for patients taking Vencure 37.5mg ER tablets; dose reduction or treatment discontinuation should be considered if necessary.
Constipation is a known side effect of Vencure 37.5mg Tablet ER. Increase fiber and water intake; laxatives may also help. Your doctor can advise on prevention and management. Consult them if constipation persists or worsens.
Weight loss is a reported side effect of Vencure 37.5mg Tablet ER, observed in studies at higher doses over several weeks. Consult your doctor if this concerns you.
Vencure 37.5mg Extended-Release Tablets are not habit-forming.
Consult your doctor before substituting a tablet for a capsule; the differing formulations may affect drug release and treatment efficacy, potentially causing side effects or treatment failure. Self-substitution is not recommended.
Yes, gabapentin can be combined with Vencure 37.5mg ER tablets, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Vencure 37.5mg Extended-Release tablets.
Vencure 37.5mg Extended-Release Tablets are not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Vencure 37.5mg Extended-Release Tablets have shown efficacy in some research studies and are therefore sometimes used off-label for this condition.
Vencure 37.5mg Extended-Release tablets affect brain neurotransmitters, reducing appetite in a dose-dependent manner.
Should you experience side effects such as reduced libido or impotence, consult your doctor to discuss alternative treatment options. Do not discontinue Vencure 37.5mg Tablet ER without medical supervision, as this may worsen side effects.
Vencure 37.5mg Tablet ER
33
MRP 38
13% off